About this trial
The aim of this study is the clinical and radiographic evaluation of (Platelet-Rich Fibrin (PRF) versus Mineral Trioxide Aggregate (MTA) in indirect pulp capping when used with deep carious molars over 1 year follow up.
Eligibility criteria
Qualifiers
o Patients with asymptomatic deep carious molars.
Patients with clinically and radiographically confirmed deep carious lesions that do not exhibit spontaneous pain.
Permanent molars only.
Teeth with intact or minimally restored occlusal surfaces (i.e., no extensive restorations or fractures).
Disqualifiers
o Patients with systemic conditions affecting bone or tissue healing (e.g., uncontrolled diabetes, osteoporosis, immunosuppressed conditions).
Pregnant or lactating women (if applicable to your study).
Teeth with pulp exposure or necrotic pulp.
Presence of symptomatic irreversible pulpitis (e.g., spontaneous pain, lingering pain).
Trial design
Treatments tested in this trial
- MTA
- PRF